Tyme Technologies, Inc. announced Christine D. Baker has been appointed to company's Board of Directors. Ms. Baker brings over 30 years of experience in the biotech/pharmaceutical industry, with expertise in business development, commercialization, and drug development strategies. She is currently the Chief Business Officer of Hookipa Pharma.
The Company is also announcing that co-founder Steven Hoffman has stepped down from his role as Chief Scientific Officer but will continue to support TYME's efforts as a member of the Board of Directors. Mr. Michels, who currently serves on TYME's Board of Directors as Lead Independent Director, will assume the role of Chairman of the Board. Mr. Michels, who has served on TYME's Board of Directors since October 2018, has over 39 years of experience in the healthcare industry. Most recently, he served as President and Chief Executive Officer of OraSure Technologies, Inc.